Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobutomo Tsuruzoe is active.

Publication


Featured researches published by Nobutomo Tsuruzoe.


Archive | 1992

5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones

Keizo Tanikawa; Akira Saito; Takashi Matsumoto; Ryozo Sakoda; Nobutomo Tsuruzoe; Ken-ichi Shikada


Archive | 1995

Agent for prophylaxis and treatment of thromboxane A2-mediated diseases

Ruriko Ikegawa; Teruaki Imada; Norifumi Nakamura; Keizo Tanikawa; Nobutomo Tsuruzoe


Archive | 1991

5-arylmethylamino-6-oxy-substituted 3(2h)-pyridazinones

Keizo Tanikawa; Akira Saito; Takashi Matsumoto; Ryozo Sakoda; Nobutomo Tsuruzoe; Ken-ichi Shikada


Archive | 1999

Remedial agent for erectile dysfunction

Keizo Tanikawa; Nobutomo Tsuruzoe; Norimasa Shudo; Toru Yamashita; Norihisa Ishiwata; Hideaki Kido; Hajime Ebisu; Kazutaka Hayashi; Yoshiji Kubo; Norifumi Nakamura


Archive | 2010

megakaryopoiesis and thrombopoiesis A novel nonpeptidyl human c-Mpl activator stimulates human

Mamoru Ito; Yasuyuki Ohnishi; Norihisa Ishiwata; Yasuo Ikeda; Nobutomo Tsuruzoe; Takanori Nakamura; Yoshitaka Miyakawa; Atsushi Miyamura; Akiko Yamane; Hidenori Suzuki


Archive | 2009

Vascular intimal hyperplasia inhibitor

Hiroshi Nishiyama; Norimasa Shudo; Nobutomo Tsuruzoe


Archive | 2005

3(2h)-pyridazinone compounds as vascular intimal hyperplasia inhibitor

Hiroshi Nishiyama; Norimasa Shudo; Nobutomo Tsuruzoe


Archive | 1999

Agent therapeutique pour le traitement de la dyserection

Keizo Tanikawa; Nobutomo Tsuruzoe; Norimasa Shudo; Toru Yamashita; Norihisa Ishiwata; Hideaki Kido; Hajime Ebisu; Kazutaka Hayashi; Yoshiji Kubo; Norifumi Nakamura


Archive | 1996

DERIVATIVES OF 3(2H)-PYRIDAZINONE AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON THEIR BASE

Kejzo Tanikava; Akira Saito; Takasi Matsumoto; Riozo Sakoda; Nobutomo Tsuruzoe; Ken-Iti Sikada


Archive | 1995

Agent for the prevention and treatment of thromboxane A2 mediated diseases

Ruriko Ikegawa; Teruaki Imada; Norifumi Nakamura; Keizo Tanikawa; Nobutomo Tsuruzoe

Collaboration


Dive into the Nobutomo Tsuruzoe's collaboration.

Top Co-Authors

Avatar

Norimasa Shudo

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Norifumi Nakamura

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Teruaki Imada

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge